Piramal Pharma's Stock Sees Decline, But Long Term Outlook Remains Positive

Piramal Pharma, a leading pharmaceutical company in the largecap industry, has recently seen a decline in its stock price. On November 11, 2024, the company's stock lost -3.48%, underperforming the sector by -3.14%. This has led to a 'Hold' call by MarketsMOJO for the stock.

In the past three days, Piramal Pharma's stock has been on a downward trend, falling by -7.34%. On the same day, the stock touched an intraday low of Rs 271.55 (-3.64%). However, the stock is still performing well in the long term, with its moving averages higher than 20 day, 50 day, 100 day, and 200 day moving averages.

In comparison to the Sensex performance, Piramal Pharma's stock has underperformed with a -2.54% return in the last day, while the Sensex has seen a 0.11% increase. However, in the past month, the stock has outperformed the Sensex with a 23.72% return, while the Sensex has seen a -2.22% decline.

Piramal Pharma continues to be a strong player in the pharmaceutical industry, with its largecap size and consistent performance. While the recent decline in stock price may be a cause for concern, the company's long term performance and moving averages suggest a positive outlook for the future. Investors are advised to hold onto their stocks and monitor the company's performance in the coming days.